spacer
home > ict > winter 2009 > strength in unity
PUBLICATIONS
International Clinical Trials

Strength in Unity

 

THE GROWING CHALLENGE

It is no secret that the effort and costs involved with conducting a clinical study have dramatically increased. The Tufts Center for the Study of Drug Development reported earlier this year that trials have become more complex, with a 6.5 per cent growth rate in the number of unique procedures per protocol between 1999 and 2005, and are taking more time with the number of days from protocol design to database lock, rising by nearly 70 per cent between 1999-2002 and 2003-2006. With healthcare evolving toward personalised medicine, and a growing push toward adaptive clinical trial design, the need for flexibility in managing greater numbers of clinical studies will be critical. With laboratory data playing a key role in most clinical trials, the laboratory informatics systems employed must be flexible and agile, as well as capable of coping with the challenges and complexities of current and future clinical studies.

SHORTCOMINGS OF THE TRADITIONAL APPROACH

In order to manage laboratory operations in regulatory compliant fashion, multiple software systems are often deployed. These can include clinical trial management systems (CTMS), laboratory information management systems (LIMS and/or LIS), and  biobanking software, electronic laboratory notebooks (ELN) and method or laboratory execution systems (MES/LES). Furthermore, a variety of legacy software systems may be present within a multi-site enterprise due to corporate evolution and mergers/acquisitions. ‘Flexible’ and ‘agile’ are not typically adjectives that an IT manager would use to describe such a patchwork of multiple laboratory informatics systems used to support clinical trial laboratory operations.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Ed Krasovec is the Director of Clinical Operations for STARLIMS Corporation. He oversees business development, product management and project implementation for clinical laboratory applications, including healthcare, biospecimen management and clinical trials. During the past 10 years, Ed has founded and sold a clinical informatics company and has championed efforts to expand LIMS presence in clinical laboratory applications. He has 15 years of management and technical experience with DuPont in laboratory management, business planning, research and operations. Ed holds a BSc in Chemical Engineering from Penn State University and an MBA from Drexel University.

 

spacer
Ed Krasovec
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Surge of Indian biosimilars market forecast in 2019

16th April 2019: New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India specific findings from CPhI’s bio league tables predict strong ‘bio growth potential’ in India throughout 2019 in the build-up to the 13th edition of CPhI India 2019, which will take place at the India Expo Centre in Delhi NCR.
More info >>

White Papers

Preparation of Pharmaceutical Samples for Metals Analysis

RSSL

There has been a lot of discussion regarding the methods of analysis for pharmaceutical products as we await the upcoming changes to both the EP and USP, relating to the analysis of metal impurities.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement